Normunity
Company

Normunity

Biotechnology Untapped Biology at the Interface of the Immune System and the Tumor to Target Mechanisms That Impact Tumor Growth and Circumvent Immune Surveillance and Tumor Clearance. the Company Is Using These Novel Targets to Build a Pipeline of Anti-cancer Medicines 24 employees
Employees
24
Contacts
3
Emails
3
Phones
2

Normunity Overview

Headquarters
Untapped Biology at the Interface of the Immune System and the Tumor to Target Mechanisms That Impact Tumor Growth and Circumvent Immune Surveillance and Tumor Clearance. the Company Is Using These Novel Targets to Build a Pipeline of Anti-cancer Medicines
Industry
Biotechnology
Employees
24
Funding
75.0M

About Normunity

Normunity is a biotechnology company creating novel anti-cancer therapies that address untapped biology at the interface of the immune system and the tumor to target mechanisms that impact tumor growth and circumvent immune surveillance and tumor clearance. The company is using these novel targets to build a pipeline of anti-cancer medicines, including therapeutic antibodies, bispecific antibodies, and payload-carrying biologics. The company’s lead program, NRM‑823, is a T cell engager with tumor-specific targeting for multiple solid tumors and is expected to enter the clinic in 2025. Normunity is located in Boston, MA, and New Haven, CT.

Normunity Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Normunity Org Chart

Sample employees and titles
Name Title Contact
Darlene Deptula-Hicks Consulting/acting Chief Financial
Email Phone
Marie-Claire Peakman Partner, Pfizer Ventures - Executive
Email
Rachel W. Humphrey, Md President and Founding CEO, Normunity
Email Phone
Mitra Miri Principal at Oup - Life Sciences Vc
View

Employees by Management Level

Executive 2 profiles
Senior / Lead 1 profile
Individual contributor 1 profile

Compare Similar Companies to Normunity